• 1
    Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., Agarwala, R. et al., Initial sequencing and comparative analysis of the mouse genome. Nature 2002. 420: 520562.
  • 2
    Mestas, J. and Hughes, C. C., Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004. 172: 27312738.
  • 3
    Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R. et al., Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2013. 110: 35073512.
  • 4
    Rongvaux, A., Takizawa, H., Strowig, T., Willinger, T., Eynon, E. E., Flavell, R. A. and Manz, M. G., Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol. 2013. 31: 635674.
  • 5
    Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K. et al., Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006. 12: 13161322.
  • 6
    Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A. and Manz, M. G., Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004. 304: 104107.
  • 7
    Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T. et al., Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chainnull mice. Blood 2005. 106: 15651573.
  • 8
    Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M. et al., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005. 174: 64776489.
  • 9
    Brehm, M. A., Cuthbert, A., Yang, C., Miller, D. M., DiIorio, P., Laning, J., Burzenski, L. et al., Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgammanull mutation. Clin. Immunol. 2010. 135: 8498.
  • 10
    McDermott, S. P., Eppert, K., Lechman, E. R., Doedens, M. and Dick, J. E., Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010. 116: 193200.
  • 11
    Takenaka, K., Prasolava, T. K., Wang, J. C., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E. et al., Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 2007. 8: 13131323.
  • 12
    Legrand, N., Huntington, N. D., Nagasawa, M., Bakker, A. Q., Schotte, R., Strick-Marchand, H., de Geus, S. J. et al., Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. USA 2011. 108: 1322413229.
  • 13
    Strowig, T., Rongvaux, A., Rathinam, C., Takizawa, H., Borsotti, C., Philbrick, W., Eynon, E. E. et al., Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma c-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. USA 2011. 108: 1321813223.
  • 14
    Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E. et al., IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 2009. 206: 2534.
  • 15
    Strowig, T., Chijioke, O., Carrega, P., Arrey, F., Meixlsperger, S., Rämer, P. C., Ferlazzo, G. et al., Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 2010. 116: 41584167.
  • 16
    Pinchuk, L. M. and Filipov, N. M., Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing 2008. 5: 1.
  • 17
    Rämer, P. C., Chijioke, O., Meixlsperger, S., Leung, C. S. and Münz, C., Mice with human immune system components as in vivo models for infections with human pathogens. Immunol. Cell Biol. 2011. 89: 408416.
  • 18
    An, D. S., Poon, B., Ho Tsong Fang, R., Weijer, K., Blom, B., Spits, H., Chen, I. S. and Uittenbogaart, C. H., Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 2007. 14: 391396.
  • 19
    Gorantla, S., Sneller, H., Walters, L., Sharp, J. G., Pirruccello, S. J., West, J. T., Wood, C. et al., Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gamma c-/- mice. J. Virol. 2007. 81: 27002712.
  • 20
    Zhang, L., Kovalev, G. I. and Su, L., HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007. 109: 29782981.
  • 21
    Berges, B. K., Wheat, W. H., Palmer, B. E., Connick, E. and Akkina, R., HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology 2006. 3: 76.
  • 22
    Baenziger, S., Tussiwand, R., Schlaepfer, E., Mazzucchelli, L., Heikenwalder, M., Kurrer, M. O., Behnke, S. et al., Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc. Natl. Acad. Sci. USA 2006. 103: 1595115956.
  • 23
    Berger, E. A., Murphy, P. M. and Farber, J. M., Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999. 17: 657700.
  • 24
    Sun, Z., Denton, P. W., Estes, J. D., Othieno, F. A., Wei, B. L., Wege, A. K., Melkus, M. W. et al., Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 2007. 204: 705714.
  • 25
    Berges, B. K., Akkina, S. R., Folkvord, J. M., Connick, E. and Akkina, R., Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gamma c-/- (RAG-hu) mice. Virology 2008. 373: 342351.
  • 26
    Denton, P. W., Estes, J. D., Sun, Z. F., Othieno, F. A., Wei, B. D. L., Wege, A. K., Powell, D. A. et al., Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLS Medicine 2008. 5: 7989.
  • 27
    Murooka, T. T., Deruaz, M., Marangoni, F., Vrbanac, V. D., Seung, E., von Andrian, U. H., Tager, A. M. et al., HIV-infected T cells are migratory vehicles for viral dissemination. Nature 2012. 490: 283287.
  • 28
    Gorantla, S., Makarov, E., Dwyer, J. F., Castanedo, A., Holguin, A., Gebhart, C. L., Gendelman, H. E. et al., Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am. J. Pathol. 2010. 177: 29382949.
  • 29
    Marsden, M. D., Kovochich, M., Suree, N., Shimizu, S., Mehta, R., Cortado, R., Bristol, G. et al., HIV latency in the humanized BLT mouse. J. Virol. 2012. 86: 339347.
  • 30
    Denton, P. W., Olesen, R., Choudhary, S. K., Archin, N. M., Wahl, A., Swanson, M. D., Chateau M. et al., Generation of HIV latency in humanized BLT mice. J. Virol. 2012. 86: 630634.
  • 31
    Choudhary, S. K., Archin, N. M., Cheema, M., Dahl, N. P., Garcia, J. V. and Margolis, D. M., Latent HIV-1 infection of resting CD4+ T cells in the humanized Rag2-/- gamma c-/- mouse. J. Virol. 2012. 86: 114120.
  • 32
    Nischang, M., Sutmuller, R., Gers-Huber, G., Audige, A., Li, D., Rochat, M. A., Baenziger, S. et al., Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting antiretroviral drugs for treating HIV-1. PLoS ONE 2012. 7: e38853.
  • 33
    Chateau, M. L., Denton, P. W., Swanson, M. D., McGowan, I. and Garcia, J. V., Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice. PLoS ONE 2013. 8: e60024.
  • 34
    Wahl, A., Swanson, M. D., Nochi, T., Olesen, R., Denton, P. W., Chateau, M. and Garcia, J. V., Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathogens 2012. 8: e1002732.
  • 35
    Kumar, P., Ban, H. S., Kim, S. S., Wu, H. Q., Pearson, T., Greiner, D. L., Laouar, A. et al., T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008. 134: 577586.
  • 36
    van Duyne, R., Cardenas, J., Easley, R., Wu, W., Kehn-Hall, K., Klase, Z., Mendez, S. et al., Effect of transcription peptide inhibitors on HIV-1 replication. Virology 2008. 376: 308322.
  • 37
    Wheeler, L. A., Vrbanac, V., Trifonova, R., Brehm, M. A., Gilboa-Geffen, A., Tanno, S., Greiner, D. L. et al., Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras. Mol. Ther. 2013. 21: 13781389.
  • 38
    Strowig, T., Gurer, C., Ploss, A., Liu, Y. F., Arrey, F., Sashihara, J., Koo, G. et al., Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 2009. 206: 14231434.
  • 39
    Islas-Ohlmayer, M., Padgett-Thomas, A., Domiati-Saad, R., Melkus, M. W., Cravens, P. D., Martin Mdel, P., Netto, G. et al., Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J. Virol. 2004. 78: 1389113900.
  • 40
    Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M. et al., A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008. 198: 673682.
  • 41
    Miller, G. and Lipman, M., Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J. Exp. Med. 1973. 138: 13981412.
  • 42
    Sato, K., Misawa, N., Nie, C., Satou, Y., Iwakiri, D., Matsuoka, M., Takahashi, R. et al., A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011. 117: 56635673.
  • 43
    Kutok, J. L. and Wang, F., Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 2006. 1: 375404.
  • 44
    Cocco, M., Bellan, C., Tussiwand, R., Corti, D., Traggiai, E., Lazzi, S., Mannucci, S. et al., CD34+ cord blood cell-transplanted Rag2-/- gamma c-/- mice as a model for Epstein-Barr virus infection. Am. J. Pathol. 2008. 173: 13691378.
  • 45
    Ma, S. D., Hegde, S., Young, K. H., Sullivan, R., Rajesh, D., Zhou, Y., Jankowska-Gan, E. et al., A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 2011. 85: 165177.
  • 46
    Wahl, A., Linnstaedt, S. D., Esoda, C., Krisko, J. F., Martinez-Torres, F., Delecluse, H. J., Cullen, B. R. et al., A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo. J. Virol. 2013. 87: 54375446.
  • 47
    White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B. et al., EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Invest. 2012. 122: 14871502.
  • 48
    Babcock, J. G., Hochberg, D. and Thorley-Lawson, A. D., The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000. 13: 497506.
  • 49
    Jaiswal, S., Pazoles, P., Woda, M., Shultz, L. D., Greiner, D. L., Brehm, M. A. and Mathew, A., Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology 2012. 136: 334343.
  • 50
    Jaiswal, S., Pearson, T., Friberg, H., Shultz, L. D., Greiner, D. L., Rothman, A. L. and Mathew, A., Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE 2009. 4: e7251.
  • 51
    Kuruvilla, J. G., Troyer, R. M., Devi, S. and Akkina, R., Dengue virus infection and immune response in humanized RAG2-/-gamma c-/- (RAG-hu) mice. Virology 2007. 369: 143152.
  • 52
    Tan, C. S., Broge, T. A., Jr., Seung, E., Vrbanac, V., Viscidi, R., Gordon, J., Tager, A. M. et al., Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS ONE 2013. 8: e64313.
  • 53
    Kwant-Mitchell, A., Ashkar, A. A. and Rosenthal, K. L., Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J. Virol. 2009. 83: 1066410676.
  • 54
    Banerjee, P., Tripp, A., Lairmore, M. D., Crawford, L., Sieburg, M., Ramos, J. C., Harrington, W. et al., Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 2010. 115: 26402648.
  • 55
    Smith, M. S., Goldman, D. C., Bailey, A. S., Pfaffle, D. L., Kreklywich, C. N., Spencer, D. B., Othieno, F. A. et al., Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 2010. 8: 284291.
  • 56
    Washburn, M. L., Bility, M. T., Zhang, L., Kovalev, G. I., Buntzman, A., Frelinger, J. A., Barry, W. et al., A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011. 140: 13341344.
  • 57
    Marodon, G., Desjardins, D., Mercey, L., Baillou, C., Parent, P., Manuel, M., Caux, C. et al., High diversity of the immune repertoire in humanized NOD.SCID.gamma c-/- mice. Eur. J. Immunol. 2009. 39: 21362145.
  • 58
    Becker, P. D., Legrand, N., van Geelen, C. M. M., Noerder, M., Huntington, N. D., Lim, A., Yasuda, E. et al., Generation of human antigen-specific monoclonal IgM antibodies using vaccinated “human immune system’’ mice. PLoS ONE 2010. 5: e13137.
  • 59
    Pham, H. P., Manuel, M., Petit, N., Klatzmann, D., Cohen-Kaminsky, S., Six, A. and Marodon, G., Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice. Eur. J. Immunol. 2012. 42: 760770.
  • 60
    Ippolito, G. C., Hoi, K. H., Reddy, S. T., Carroll, S. M., Ge, X., Rogosch, T., Zemlin, M. et al., Antibody repertoires in humanized NOD-scid-IL2R gammanull mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS ONE 2012. 7: e35497.
  • 61
    Parietti, V., Nelson, E., Telliam, G., Le Noir, S., Pla, M., Delord, M., Vanneaux, V. et al., Dynamics of human prothymocytes and xenogeneic thymopoiesis in hematopoietic stem cell-engrafted nonobese diabetic-SCID/IL-2r gammanull Mice. J. Immunol. 2012. 189: 16481660.
  • 62
    Meixlsperger, S., Leung, C. S., Rämer, P. C., Pack, M., Vanoaica, L. D., Breton, G., Pascolo, S. et al., CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 2013. 121: 50345044.
  • 63
    Hofmann, J., Greter, M., Du Pasquier, L. and Becher, B., B-cells need a proper house, whereas T-cells are happy in a cave: the dependence of lymphocytes on secondary lymphoid tissues during evolution. Trends Immunol. 2010. 31: 144153.
  • 64
    Brainard, D. M., Seung, E., Frahm, N., Cariappa, A., Bailey, C. C., Hart, W. K., Shin, H. S. et al., Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J. Virol. 2009. 83: 73057321.
  • 65
    Lang, J. L., Kelly, M., Freed, B. M., McCarter, M. D., Kedl, R. M., Torres, R. M. and Pelanda, R., Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J. Immunol. 2013. 190: 20902101.
  • 66
    Klein, F., Halper-Stromberg, A., Horwitz, J. A., Gruell, H., Scheid, J. F., Bournazos, S., Mouquet, H. et al., HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012. 492: 118–122.
  • 67
    Hur, E. M., Patel, S. N., Shimizu, S., Rao, D. S., Gnanapragasam, P. N. P., An, D. S., Yang, L. L. et al., Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 2012. 120: 45714582.
  • 68
    Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., Vaira, D., Vandergeeten, C. et al., An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2R gammaNULL mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE 2012. 7: e38491.
  • 69
    Palmer, B. E., Neff, C. P., Lecureux, J., Ehler, A., Dsouza, M., Remling-Mulder, L., Korman, A. J. et al., In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice. J. Immunol. 2013. 190: 211219.
  • 70
    Shultz, L. D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T. et al., Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gammanull humanized mice. Proc. Natl. Acad. Sci. USA 2010. 107: 1302213027.
  • 71
    Dudek, T. E., No, D. C., Seung, E., Vrbanac, V. D., Fadda, L., Bhoumik, P., Boutwell, C. L. et al., Rapid evolution of HIV-1 to functional CD8+ T cell responses in humanized BLT mice. Sci. Transl. Med. 2012. 4: 143ra98.
  • 72
    Sato, Y., Nagata, S. and Takiguchi, M., Effective elicitation of human effector CD8+ T cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1. PLoS ONE 2012. 7: e42776.
  • 73
    Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M. et al., T cell-mediated control of Epstein-Barr virus infection in humanized mice. J. Infect. Dis. 2009. 200: 16111615.
  • 74
    Gorantla, S., Makarov, E., Finke-Dwyer, J., Gebhart, C. L., Domm, W., Dewhurst, S., Gendelman, H. E. et al., CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J. Immunol. 2010. 184: 70827091.
  • 75
    Sato, K., Izumi, T., Misawa, N., Kobayashi, T., Yamashita, Y., Ohmichi, M., Ito, M. et al., Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J. Virol. 2010. 84: 95469556.
  • 76
    Krisko, J. F., Martinez-Torres, F., Foster, J. L. and Garcia, J. V., HIV restriction by APOBEC3 in humanized mice. PLoS Pathogens 2013. 9: e1003242.
  • 77
    Zhang, L., Jiang, Q., Li, G., Jeffrey, J., Kovalev, G. I. and Su, L., Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2-/-gamma C-/- mice in vivo. Blood 2011. 117: 61846192.
  • 78
    Yu, C. I., Becker, C., Wang, Y., Marches, F., Helft, J., Leboeuf, M., Anguiano, E. et al., Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity 2013. 38: 818830.
  • 79
    Heuts, F., Gavier-Widen, D., Carow, B., Juarez, J., Wigzell, H. and Rottenberg, M. E., CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc. Natl. Acad. Sci. USA 2013. 110: 64826487.
  • 80
    Calderon, V. E., Valbuena, G., Goez, Y., Judy, B. M., Huante, M. B., Sutjita, P., Johnston, R. K. et al., A humanized mouse model of tuberculosis. PLoS ONE 2013. 8: e63331.
  • 81
    Song, J., Willinger, T., Rongvaux, A., Eynon, E. E., Stevens, S., Manz, M. G., Flavell, R. A. et al., A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 2010. 8: 369376.
  • 82
    Libby, S. J., Brehm, M. A., Greiner, D. L., Shultz, L. D., McClelland, M., Smith, K. D., Cookson, B. T. et al., Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc. Natl. Acad. Sci. USA 2010. 107: 1558915594.
  • 83
    Firoz Mian, M., Pek, E. A., Chenoweth, M. J. and Ashkar, A. A., Humanized mice are susceptible to Salmonella typhi infection. Cell. Mol. Immunol. 2011. 8: 8387.